Investor List:

Top BioTech Series B Investors in Canada (17)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top BioTech investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of James C. Murray, Partner at ExSight Capital Management
James C. Murray
Sweet spot: $1M
Range: $200K - $4.0M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Diagnostics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Hardware (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Robotics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Hardware (Pre-seed), Investors in Robotics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Therapeutics (Seed), Investors in Medical Devices (Seed), Investors in Diagnostics (Seed), Investors in Health & Hospital Services (Seed), Investors in Digital Health (Seed), Investors in Therapeutics (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Drug Delivery (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Digital Health (Series A), Investors in Therapeutics (Series A), Investors in Hardware (Series A), Investors in Diagnostics (Series A), Investors in Robotics (Series A), Investors in Therapeutics (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Hardware (Series A), Investors in Robotics (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Hardware (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Therapeutics (Series B), Investors in Health & Hospital Services (Series B), Investors in Diagnostics (Series B), Investors in BioTech (Series B), Investors in Therapeutics (Series B), Investors in Robotics (Series B), Investors in Drug Delivery (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Hardware (Series B), Investors in Robotics (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Canada (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists)
Photo of Terrence Rohan, Managing Director at Otherwise Fund
Terrence Rohan
Otherwise Fund·Managing Director
Sweet spot: $500K
Range: $100K - $1M
Investors in Canada, Investors in United States, Investors in San Francisco (CA)
Investors in Generative Tech/AI (Seed), Investors in Web3/Crypto (Seed), Investors in BioTech (Seed), Investors in Web3/Blockchain (Seed), Investors in Marketplaces (Seed), Investors in SaaS (Seed), Investors in Consumer Internet (Seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Seed), Investors in Web3/Blockchain (Seed), Investors in BioTech (Seed), Investors in Web3/Crypto (Seed), Investors in Marketplaces (Seed), Investors in Marketplaces (Seed), Investors in Web3/Blockchain (Seed), Investors in SaaS (Seed), Investors in BioTech (Seed), Investors in SaaS (Seed), Investors in Consumer Internet (Seed), Investors in Web3/Crypto (Seed), Investors in Consumer Internet (Seed), Investors in Generative Tech/AI (Series A), Investors in BioTech (Series A), Investors in Marketplaces (Series A), Investors in SaaS (Series A), Investors in Web3/Blockchain (Series A), Investors in Web3/Crypto (Series A), Investors in Consumer Internet (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series A), Investors in Web3/Blockchain (Series A), Investors in BioTech (Series A), Investors in Web3/Crypto (Series A), Investors in Marketplaces (Series A), Investors in Marketplaces (Series A), Investors in Web3/Blockchain (Series A), Investors in BioTech (Series A), Investors in SaaS (Series A), Investors in SaaS (Series A), Investors in Web3/Crypto (Series A), Investors in Consumer Internet (Series A), Investors in Consumer Internet (Series A), Investors in Generative Tech/AI (Series B), Investors in BioTech (Series B), Investors in Web3/Blockchain (Series B), Investors in Web3/Crypto (Series B), Investors in SaaS (Series B), Investors in Marketplaces (Series B), Investors in Consumer Internet (Series B), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series B), Investors in Web3/Blockchain (Series B), Investors in Web3/Crypto (Series B), Investors in Web3/Blockchain (Series B), Investors in BioTech (Series B), Investors in Marketplaces (Series B), Investors in Marketplaces (Series B), Investors in SaaS (Series B), Investors in BioTech (Series B), Investors in SaaS (Series B), Investors in Consumer Internet (Series B), Investors in Web3/Crypto (Series B), Investors in Consumer Internet (Series B), Investors in Canada (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of robert giles, Managing Director at CE VENTURE CAPITAL
robert giles
CE VENTURE CAPITAL·Managing Director
Sweet spot: $750K
Range: $250K - $5.0M
Investors in San Diego (CA), Investors in Austin (TX), Investors in New York (NY), Investors in Mexico (Mexico), Investors in Europe, Investors in Canada, Investors in United States, Investors in Israel, Investors in SF Bay Area (CA), Investors in Boston (MA), Investors in Boulder (CO)
Investors in Sales & CRM (Seed), Investors in Sales & CRM (Seed), Investors in Security (Seed), Investors in Analytics (Seed), Investors in Analytics (Seed), Investors in Sales & CRM (Seed), Investors in Security (Seed), Investors in BioTech (Seed), Investors in Hardware (Seed), Investors in Hardware (Seed), Investors in Sales & CRM (Seed), Investors in Sales & CRM (Seed), Investors in Data Services (Seed), Investors in Sales & CRM (Seed), Investors in Security (Seed), Investors in Hardware (Seed), Investors in Data Services (Seed), Investors in Hardware (Seed), Investors in Security (Seed), Investors in Cloud Infrastructure (Seed), Investors in Cloud Infrastructure (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Analytics (Seed), Investors in Security (Seed), Investors in BioTech (Seed), Investors in Data Services (Seed), Investors in Cloud Infrastructure (Seed), Investors in Analytics (Seed), Investors in Data Services (Seed), Investors in Security (Seed), Investors in Hardware (Seed), Investors in Hardware (Seed), Investors in Data Services (Seed), Investors in Sales & CRM (Seed), Investors in Cloud Infrastructure (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Data Services (Seed), Investors in Enterprise (Seed), Investors in Analytics (Seed), Investors in Analytics (Seed), Investors in Cloud Infrastructure (Seed), Investors in Hardware (Seed), Investors in Enterprise (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed), Investors in AI (Seed), Investors in SaaS (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed), Investors in Security (Seed), Investors in Cloud Infrastructure (Seed), Investors in SaaS (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Analytics (Seed), Investors in Sales & CRM (Seed), Investors in Data Services (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Cloud Infrastructure (Seed), Investors in Enterprise (Seed), Investors in Hardware (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed), Investors in SaaS (Seed), Investors in Sales & CRM (Seed), Investors in Security (Seed), Investors in Analytics (Seed), Investors in Data Services (Seed), Investors in Hardware (Seed), Investors in AI (Seed), Investors in SaaS (Seed), Investors in BioTech (Seed), Investors in Security (Seed), Investors in Analytics (Seed), Investors in Enterprise (Seed), Investors in Data Services (Seed), Investors in Cloud Infrastructure (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Cloud Infrastructure (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed), Investors in AI (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed), Investors in Sales & CRM (Series A), Investors in Sales & CRM (Series A), Investors in Analytics (Series A), Investors in Analytics (Series A), Investors in Security (Series A), Investors in Hardware (Series A), Investors in BioTech (Series A), Investors in Security (Series A), Investors in Hardware (Series A), Investors in Sales & CRM (Series A), Investors in Hardware (Series A), Investors in Sales & CRM (Series A), Investors in Cloud Infrastructure (Series A), Investors in BioTech (Series A), Investors in Cloud Infrastructure (Series A), Investors in Hardware (Series A), Investors in Hardware (Series A), Investors in Security (Series A), Investors in Data Services (Series A), Investors in Data Services (Series A), Investors in BioTech (Series A), Investors in Security (Series A), Investors in Sales & CRM (Series A), Investors in Data Services (Series A), Investors in Security (Series A), Investors in Analytics (Series A), Investors in Sales & CRM (Series A), Investors in BioTech (Series A), Investors in Cloud Infrastructure (Series A), Investors in Hardware (Series A), Investors in AI (Series A), Investors in Hardware (Series A), Investors in Security (Series A), Investors in Analytics (Series A), Investors in Enterprise (Series A), Investors in Analytics (Series A), Investors in Data Services (Series A), Investors in Analytics (Series A), Investors in BioTech (Series A), Investors in Data Services (Series A), Investors in Enterprise (Series A), Investors in Sales & CRM (Series A), Investors in SaaS (Series A), Investors in Data Services (Series A), Investors in AI (Series A), Investors in Cloud Infrastructure (Series A), Investors in Enterprise (Series A), Investors in SaaS (Series A), Investors in Security (Series A), Investors in Cloud Infrastructure (Series A), Investors in AI (Series A), Investors in SaaS (Series A), Investors in Enterprise (Series A), Investors in Cloud Infrastructure (Series A), Investors in SaaS (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Analytics (Series A), Investors in Sales & CRM (Series A), Investors in AI (Series A), Investors in Enterprise (Series A), Investors in Hardware (Series A), Investors in SaaS (Series A), Investors in Data Services (Series A), Investors in Cloud Infrastructure (Series A), Investors in SaaS (Series A), Investors in Sales & CRM (Series A), Investors in Enterprise (Series A), Investors in Hardware (Series A), Investors in Analytics (Series A), Investors in AI (Series A), Investors in Security (Series A), Investors in Data Services (Series A), Investors in BioTech (Series A), Investors in SaaS (Series A), Investors in Security (Series A), Investors in Analytics (Series A), Investors in Enterprise (Series A), Investors in Data Services (Series A), Investors in BioTech (Series A), Investors in Cloud Infrastructure (Series A), Investors in AI (Series A), Investors in SaaS (Series A), Investors in Cloud Infrastructure (Series A), Investors in Enterprise (Series A), Investors in AI (Series A), Investors in SaaS (Series A), Investors in Enterprise (Series A), Investors in Analytics (Series B), Investors in Sales & CRM (Series B), Investors in Security (Series B), Investors in Cloud Infrastructure (Series B), Investors in Cloud Infrastructure (Series B), Investors in Data Services (Series B), Investors in Hardware (Series B), Investors in Hardware (Series B), Investors in Security (Series B), Investors in Analytics (Series B), Investors in Analytics (Series B), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Data Services (Series B), Investors in Hardware (Series B), Investors in Security (Series B), Investors in Hardware (Series B), Investors in Sales & CRM (Series B), Investors in Sales & CRM (Series B), Investors in Security (Series B), Investors in Hardware (Series B), Investors in BioTech (Series B), Investors in Security (Series B), Investors in BioTech (Series B), Investors in Hardware (Series B), Investors in Sales & CRM (Series B), Investors in Cloud Infrastructure (Series B), Investors in Sales & CRM (Series B), Investors in Analytics (Series B), Investors in Data Services (Series B), Investors in Sales & CRM (Series B), Investors in Enterprise (Series B), Investors in BioTech (Series B), Investors in SaaS (Series B), Investors in Data Services (Series B), Investors in Enterprise (Series B), Investors in Security (Series B), Investors in Enterprise (Series B), Investors in AI (Series B), Investors in SaaS (Series B), Investors in Hardware (Series B), Investors in Cloud Infrastructure (Series B), Investors in AI (Series B), Investors in Analytics (Series B), Investors in SaaS (Series B), Investors in Sales & CRM (Series B), Investors in AI (Series B), Investors in Data Services (Series B), Investors in Cloud Infrastructure (Series B), Investors in Security (Series B), Investors in Data Services (Series B), Investors in Analytics (Series B), Investors in Cloud Infrastructure (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in SaaS (Series B), Investors in AI (Series B), Investors in SaaS (Series B), Investors in AI (Series B), Investors in AI (Series B), Investors in Hardware (Series B), Investors in Enterprise (Series B), Investors in Sales & CRM (Series B), Investors in Analytics (Series B), Investors in SaaS (Series B), Investors in BioTech (Series B), Investors in Data Services (Series B), Investors in Cloud Infrastructure (Series B), Investors in Sales & CRM (Series B), Investors in Enterprise (Series B), Investors in Hardware (Series B), Investors in Analytics (Series B), Investors in AI (Series B), Investors in Data Services (Series B), Investors in BioTech (Series B), Investors in SaaS (Series B), Investors in Security (Series B), Investors in Analytics (Series B), Investors in Enterprise (Series B), Investors in Security (Series B), Investors in Data Services (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Cloud Infrastructure (Series B), Investors in SaaS (Series B), Investors in Cloud Infrastructure (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in SaaS (Series B), Investors in Enterprise (Series B), Investors in Colorado / Utah (Other Lists), Investors in Canada (Other Lists), Investors in LatAm (Latin America) (Other Lists), Investors in Austin (Other Lists), Investors in Israel (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Xinhong Lim, Managing Director at Vickers Venture Partners
Xinhong Lim
Vickers Venture Partners·Managing Director
Sweet spot: $5.0M
Range: $3.0M - $10.0M
Investors in Singapore, Investors in United Kingdom, Investors in United States, Investors in China, Investors in Indonesia, Investors in Canada
Investors in Chemicals (Series A), Investors in Semiconductors (Series A), Investors in Pharmaceuticals (Series A), Investors in Material Science (Series A), Investors in Therapeutics (Series A), Investors in Medical Devices (Series A), Investors in Therapeutics (Series A), Investors in EnergyTech (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Chemicals (Series A), Investors in AI (Series A), Investors in Material Science (Series A), Investors in Semiconductors (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in EnergyTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Material Science (Series B), Investors in Semiconductors (Series B), Investors in Chemicals (Series B), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Series B), Investors in EnergyTech (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Therapeutics (Series B), Investors in Chemicals (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in AI (Series B), Investors in Material Science (Series B), Investors in Semiconductors (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in EnergyTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Canada (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Soyoung Park, General Partner at 1004 Venture Partners
Soyoung Park
1004 Venture Partners·General Partner
Sweet spot: $500K
Range: $100K - $10.0M
Investors in South Korea, Investors in Japan, Investors in Europe, Investors in United Kingdom, Investors in Canada, Investors in United States
Investors in Therapeutics (Seed), Investors in Wellness & Fitness (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Generative Tech/AI (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Generative Tech/AI (Seed), Investors in Wellness & Fitness (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Seed), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Wellness & Fitness (Series A), Investors in Digital Health (Series A), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Generative Tech/AI (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Series A), Investors in Wellness & Fitness (Series A), Investors in Generative Tech/AI (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Therapeutics (Series A), Investors in Wellness & Fitness (Series B), Investors in Diagnostics (Series B), Investors in Generative Tech/AI (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Therapeutics (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Robotics (Series B), Investors in Therapeutics (Series B), Investors in Diagnostics (Series B), Investors in Wellness & Fitness (Series B), Investors in Generative Tech/AI (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in Robotics (Series B), Investors in Canada (Other Lists), Investors in San Francisco Bay Area (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Female Investors (Other Lists), Investors in Investors who invested in diverse founders (Other Lists)
Photo of Ed Phillips, Partner at Future Planet Capital
Ed Phillips
Sweet spot: $750K
Range: $300K - $2.0M
Investors in United Kingdom, Investors in California, Investors in London, Investors in Israel, Investors in Canada, Investors in Boston (MA), Investors in New York
Investors in Smart Cities/UrbanTech (Seed), Investors in Smart Cities/UrbanTech (Seed), Investors in Smart Cities/UrbanTech (Seed), Investors in Smart Cities/UrbanTech (Seed), Investors in Supply Chain Tech (Seed), Investors in Supply Chain Tech (Seed), Investors in Supply Chain Tech (Seed), Investors in AutoTech (Seed), Investors in AutoTech (Seed), Investors in Supply Chain Tech (Seed), Investors in AutoTech (Seed), Investors in AutoTech (Seed), Investors in DeepTech (Seed), Investors in AgTech (Seed), Investors in AgTech (Seed), Investors in Smart Cities/UrbanTech (Seed), Investors in DeepTech (Seed), Investors in DeepTech (Seed), Investors in BioTech (Seed), Investors in DeepTech (Seed), Investors in Web3/Blockchain (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in AgTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Web3/Blockchain (Seed), Investors in BioTech (Seed), Investors in Web3/Blockchain (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in AgTech (Seed), Investors in Web3/Blockchain (Seed), Investors in BioTech (Seed), Investors in Enterprise (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in AI (Seed), Investors in Enterprise (Seed), Investors in AI (Seed), Investors in Enterprise (Seed), Investors in AutoTech (Seed), Investors in Supply Chain Tech (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Enterprise (Seed), Investors in DeepTech (Seed), Investors in AgTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Web3/Blockchain (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Enterprise (Seed), Investors in Smart Cities/UrbanTech (Series A), Investors in Smart Cities/UrbanTech (Series A), Investors in Smart Cities/UrbanTech (Series A), Investors in Supply Chain Tech (Series A), Investors in Supply Chain Tech (Series A), Investors in Smart Cities/UrbanTech (Series A), Investors in AutoTech (Series A), Investors in Supply Chain Tech (Series A), Investors in AutoTech (Series A), Investors in AutoTech (Series A), Investors in AutoTech (Series A), Investors in Supply Chain Tech (Series A), Investors in AgTech (Series A), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in Web3/Blockchain (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in AgTech (Series A), Investors in Smart Cities/UrbanTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in AgTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in DeepTech (Series A), Investors in Web3/Blockchain (Series A), Investors in BioTech (Series A), Investors in Web3/Blockchain (Series A), Investors in Web3/Blockchain (Series A), Investors in BioTech (Series A), Investors in Enterprise (Series A), Investors in AI (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Enterprise (Series A), Investors in AI (Series A), Investors in AutoTech (Series A), Investors in Supply Chain Tech (Series A), Investors in Enterprise (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Enterprise (Series A), Investors in DeepTech (Series A), Investors in AgTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Web3/Blockchain (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Enterprise (Series A), Investors in AutoTech (Series B), Investors in AutoTech (Series B), Investors in Smart Cities/UrbanTech (Series B), Investors in Smart Cities/UrbanTech (Series B), Investors in Smart Cities/UrbanTech (Series B), Investors in Supply Chain Tech (Series B), Investors in Supply Chain Tech (Series B), Investors in Supply Chain Tech (Series B), Investors in AgTech (Series B), Investors in Smart Cities/UrbanTech (Series B), Investors in DeepTech (Series B), Investors in AutoTech (Series B), Investors in AutoTech (Series B), Investors in DeepTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in BioTech (Series B), Investors in Web3/Blockchain (Series B), Investors in Supply Chain Tech (Series B), Investors in AgTech (Series B), Investors in Web3/Blockchain (Series B), Investors in DeepTech (Series B), Investors in Smart Cities/UrbanTech (Series B), Investors in AgTech (Series B), Investors in Web3/Blockchain (Series B), Investors in BioTech (Series B), Investors in DeepTech (Series B), Investors in AgTech (Series B), Investors in Web3/Blockchain (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Enterprise (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in AutoTech (Series B), Investors in AI (Series B), Investors in Supply Chain Tech (Series B), Investors in Enterprise (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in AI (Series B), Investors in DeepTech (Series B), Investors in AgTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Web3/Blockchain (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in Canada (Other Lists), Investors in Israel (Other Lists), Investors in London (Other Lists), Investors in Boston / New England (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists)
Photo of Daniella Kranjac, General Partner at Avant Bio LLC
Daniella Kranjac
Avant Bio LLC·General Partner
Sweet spot: $5.0M
Range: $3.0M - $10.0M
Investors in Switzerland, Investors in United Kingdom, Investors in Europe, Investors in Canada, Investors in United States
Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Canada (Other Lists), Investors in Female Investors (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists)
Photo of Alex Brufsky, Partner at 1435 Capital SLLC
Alex Brufsky
Sweet spot: $1M
Range: $250K - $10.0M
Investors in Canada, Investors in United States
Investors in AR/VR (Seed), Investors in AgTech (Seed), Investors in Payments (Seed), Investors in IoT (Seed), Investors in BioTech (Seed), Investors in Analytics (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in FinTech (Seed), Investors in AI (Seed), Investors in AR/VR (Seed), Investors in Payments (Seed), Investors in AgTech (Seed), Investors in Analytics (Seed), Investors in IoT (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in FinTech (Seed), Investors in AR/VR (Series B), Investors in Payments (Series B), Investors in BioTech (Series B), Investors in Analytics (Series B), Investors in IoT (Series B), Investors in AgTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in FinTech (Series B), Investors in AI (Series B), Investors in AR/VR (Series B), Investors in AgTech (Series B), Investors in Payments (Series B), Investors in Analytics (Series B), Investors in IoT (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in FinTech (Series B), Investors in Canada (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists)